|
SG10201704803RA
|
|
Cell culture substrate comprising a laminin and a cadherin
|
|
US2012156254A1
|
|
Recombinant laminin-521
|
|
US2010203635A1
|
|
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
EP2291402A2
|
|
Antibodies against domains of laminin-332
|
|
KR20090091800A
|
|
Composition and method for enabling proliferation of pluripotent stem cells
|
|
AU5658196A
|
|
Method for pharmaceutical delivery
|
|
AU4719696A
|
|
Isolated dna sequence for a novel macrophage receptor with a collagenous domain and the polypeptide chain encoded by such a sequence
|
|
CA2201865A1
|
|
Laminin chains: diagnostic and therapeutic use
|
|
AU3745195A
|
|
Laminin chains: diagnostic and therapeutic use
|
|
WO9212163A1
|
|
A method for determining the nucleotide sequence of the gene for the alpha5(iv) chain of human type iv collagen
|
|
US5354690A
|
|
Immunological methods for the detection of the human type IV collagen α5 chain
|
|
US5114840A
|
|
Method for determining the nucleotide sequence of a novel α5(IV) chain of human type IV collagen
|
|
US4808528A
|
|
Antibody composition for the detection of malignant cells with metastatic cell activity
|
|
US4816400A
|
|
Basement membrane collagen degrading enzyme and method of purifying same
|
|
US4677058A
|
|
Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
|
